Ablynx, a Sanofi company, is a Belgian biopharmaceutical company engaged in the development of Nanobodies®. They use the company’s unique Nanobody technology to develop therapeutics in areas of high unmet medical need where Nanobodies® offer a clear promotable advantage over existing products and technologies.

The briefing was very clear and simple: add a touch of creativity to the 200-page annual report and create a new visual identity based on the many infographics. And so we did. We simply made art of the infographics.